Table 5 Physical characteristics and current medications of the Type 1 Diabetes Mellitus (T1DM) and control groups
From: Lipoprotein metabolism in patients with type 1 diabetes under intensive insulin treatment
| Â | T1DM group (n=15) | Control group (n=16) | P value |
|---|---|---|---|
Age (years) | 26.4 ± 7.0 | 28.4 ± 6.0 | 0.40 |
Age of diabetes diagnosis (years) | 12.2 ± 7.2 | - | - |
Duration of diabetes (years) | 15.7 ± 7.9 | - | - |
Body mass index (Kg/m2) | 23.2 ± 2.3 | 25.7 ± 3.6 | 0.04 |
Waist circumference (cm) | 84.3 ± 8.3 | 90.5 ± 9.4 | 0.09 |
Waist-to-hip ratio | 0.83 ± 0.04 | 0.82 ± 0.05 | 0.80 |
Current smoking (%) | 0 | 25 | 0.09 |
Arterial hypertension (%) | 2 | 0 | 0.23 |
Insulin therapy schemes | Â | Â | Â |
  Insulin dose (U · day– 1) | 48.7 ± 13.8 | - | - |
  Insulin dose (U · kg– 1 · day– 1) | 0.69 ± 0.15 | - | - |
  Insulin injections/day | 3.53 ± 0.748 | - | - |
  Insulin correction bolus (%) | 60 | - | - |
Carbohydrate counting (%) | 40 | - | - |